Capio BiosciencesMar 131 minCapio Biosciences receives QNBV Certification from Wisconsin Economic Development Corporation (WEDC)Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV program provides tax...
Capio BiosciencesDec 19, 20191 minPresenting at PMWC 2020We are very excited that Andrew Wang MD, Assoc. Prof., Dept. of Radiation Oncology, U. of North Carolina and Cofounder of Capio Biosciences will be presenti...
Capio BiosciencesOct 22, 20191 minCapio Biosciences Featured in StartUpCity Magazine's 15 Most Promising Biotech Startups - 2019Capio Biosciences is pleased to be recognized by StartUpCity magazine as one of the most promising 15 Biotech startups 2019, and for being at the forefront o...
Capio BiosciencesApr 9, 20191 minPoster presented at the American Association of Cancer Research - AACR 2019 Michael Poellmann presented "Quantification and downstream analysis of circulating tumor cells isolated using CapioCyte(TM) liquid biopsy) at the AACR annual...
Capio BiosciencesJan 3, 20191 minCapioCyte Technology in the News!Capio Biosciences "CapioCyte(TM) technology is featured in this article by John Gilmore of Genome web. https://www.genomeweb.com/cancer/circulating-tumor-cel...
Capio BiosciencesFeb 27, 20181 minSchool of Pharmacy faculty entrepreneurs bring technology from the lab to the marketplaceTwo professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic rese...
Capio BiosciencesDec 10, 20171 minPoster presented at the American Association of Pharmaceutical Scientists - AAPS 2017Seungpyo Hong presented Enhanced Sensitivity of Specificity of Circulating Tumor Cell Capture Using a Synergistic Combination of Cell Rolling and Multivalen...
